Polycystic ovary syndrome - an update.
Level 5 - mechanism / opinion, no new human data
Narrative review and guideline summary without primary human data or systematic review methodology.
What was done
This article summarizes the 2011 Australian national evidence-based guideline on the assessment and management of polycystic ovary syndrome (PCOS) tailored to general practice, with specific focus on Indigenous Australian women.
What was found
PCOS is stated to affect 12% to 21% of reproductive-aged women, with up to 70% remaining undiagnosed. The Rotterdam criteria are highlighted for diagnosis. PCOS confers an elevated risk of metabolic syndrome and cardiovascular sequelae, particularly concerning in Indigenous women with higher baseline risk. Management focuses on symptoms, fertility, psychosocial well-being, and diabetes prevention using a multidisciplinary team approach. No primary experimental or trial data are reported in the abstract.
Why it matters
The paper provides practical guidance for primary care clinicians to recognize underdiagnosed PCOS and manage its long-term cardiometabolic and reproductive risks.
Limits
The abstract represents a narrative summary of a national guideline rather than original empirical research. No primary study data, systematic review search methodology, or quantitative outcome measures are provided.
Cited by
- supports Studies show that 70% of PCOS patients are never diagnosed.